BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 101 filers reported holding BICYCLE THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $9,000 | +28.6% | 463 | +61.3% | 0.00% | – |
Q1 2024 | $7,000 | +16.7% | 287 | -17.1% | 0.00% | – |
Q4 2023 | $6,000 | -45.5% | 346 | -35.3% | 0.00% | – |
Q3 2023 | $11,000 | +10.0% | 535 | +40.1% | 0.00% | – |
Q2 2023 | $10,000 | +150.0% | 382 | +97.9% | 0.00% | – |
Q1 2023 | $4,000 | -42.9% | 193 | -8.5% | 0.00% | – |
Q4 2022 | $7,000 | +75.0% | 211 | +1.4% | 0.00% | – |
Q3 2022 | $4,000 | +33.3% | 208 | +9.5% | 0.00% | – |
Q2 2022 | $3,000 | -72.7% | 190 | -23.1% | 0.00% | – |
Q1 2022 | $11,000 | +22.2% | 247 | +63.6% | 0.00% | – |
Q4 2021 | $9,000 | +125.0% | 151 | +45.2% | 0.00% | – |
Q3 2021 | $4,000 | – | 104 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |